Alinamin Pharmaceutical Co., Ltd.

Drugs that act on the nervous system are notoriously difficult to bring to market, with unpredictable placebo responses scuppering many a late-stage trial. But there are some sparks in the darkness, a

The top listed Chinese healthcare and life sciences companies have had a strong run on the stock market over the recent past, including during the COVID-19 outbreak, with price-to-earnings (PE) multip

Takeda Pharmaceutical Co. Ltd. has raised is full fiscal year forecast for net profit attributable to owners of the company by a sizable JPY56.5bn ($535m), or 46%, to JPY180.5bn, due mainly to lower

Takeda Pharmaceutical Co. Ltd. is to shed a portfolio of non-core prescription pharmaceuticals in China, including cardiovascular and metabolism products, to local group Hasten Biopharmaceutic Co., L